Hui Sheng Biopharma bags nearly $86m in Series A+ round - DealStreetAsia

Retrieved on: 2023-01-10 09:01:05

Tags for this article:

Click the tags to see associated articles and topics

Hui Sheng Biopharma bags nearly $86m in Series A+ round - DealStreetAsia. View article details on hiswai:

Excerpt

Hui Sheng Biopharmaceutical, a subsidiary of Hong Kong-listed Sihuan Pharmaceutical Holdings Group, has secured 580 million yuan ($85.6 million) ...

Article found on: www.dealstreetasia.com